The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis...
The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Recent randomized trials have not found that polymyxin B hemoperfusion (PMX-HP) improves outcomes for patients with sepsis. However, it remains unclear whether the therapy could provide benefit for highly selected patients. Monocyte human leukocyte antigen (mHLA-DR) expression, a critical step in the immune response, is decreased during sepsis and...
Alternative Titles
Full title
The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b913db2ab99947f6a3a2a3880e43b916
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b913db2ab99947f6a3a2a3880e43b916
Other Identifiers
ISSN
1364-8535
E-ISSN
1466-609X,1364-8535
DOI
10.1186/s13054-018-2077-y
